Menu

Stars of the Show: The Immune System Plays a Pivotal Role in Tumor Formation, Development, and Metastasis

Learn which immune cells are involved in the body's natural response against cancer along with their mechanisms of action in this poster from The Scientist and Bethyl Laboratories, Inc.

Jun 1, 2018
The Scientist Creative Services Team

Cancer cells are inherently antigenic, which normally allows immune cells to identify and eliminate them prior to tumor formation. However, cancer cells have developed methods to evade or outpace immune-mediated killing, leading to tumor formation. Understanding this relationship between immune and cancer cells is therefore integral to restoring immune system potency for cancer therapeutics. There are many different immune-cell types involved in cancer cell elimination and tumor formation, each with their own mechanisms of action and defining cellular markers. The stars of this show each have their own stories to tell.

Download this poster from The Scientist, sponsored by Bethyl Laboratories, Inc., to learn  about how researchers can identify and label immune cells involved in the body's natural response against cancer cells!

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.